Equities research analysts predict that AmerisourceBergen (NYSE:ABC) will announce sales of $40.49 billion for the current fiscal quarter, according to Zacks Investment Research. Seven analysts have made estimates for AmerisourceBergen’s earnings. The lowest sales estimate is $39.86 billion and the highest is $41.32 billion. AmerisourceBergen reported sales of $37.15 billion during the same quarter last year, which indicates a positive year over year growth rate of 9%. The business is scheduled to issue its next earnings report before the market opens on Wednesday, May 2nd.

According to Zacks, analysts expect that AmerisourceBergen will report full year sales of $167.56 billion for the current financial year, with estimates ranging from $166.20 billion to $168.79 billion. For the next fiscal year, analysts anticipate that the business will report sales of $179.63 billion per share, with estimates ranging from $176.51 billion to $182.55 billion. Zacks’ sales calculations are a mean average based on a survey of sell-side research analysts that follow AmerisourceBergen.

How to Become a New Pot Stock Millionaire

AmerisourceBergen (NYSE:ABC) last released its quarterly earnings results on Tuesday, February 6th. The company reported $1.55 earnings per share for the quarter, beating the consensus estimate of $1.35 by $0.20. AmerisourceBergen had a return on equity of 53.65% and a net margin of 0.66%. The firm had revenue of $40.47 billion for the quarter, compared to analysts’ expectations of $40.42 billion. During the same quarter last year, the firm posted $1.36 EPS. The company’s revenue was up 6.0% compared to the same quarter last year.

Several research firms have weighed in on ABC. Zacks Investment Research cut AmerisourceBergen from a “hold” rating to a “sell” rating in a report on Thursday, April 12th. Royal Bank of Canada set a $101.00 price objective on AmerisourceBergen and gave the company a “hold” rating in a report on Monday, April 2nd. Barclays decreased their price objective on AmerisourceBergen from $104.00 to $95.00 and set an “equal weight” rating on the stock in a report on Tuesday, March 27th. Argus raised their price objective on AmerisourceBergen from $93.96 to $115.00 and gave the company a “buy” rating in a report on Monday, March 5th. Finally, Cowen reissued a “buy” rating and set a $108.00 price objective on shares of AmerisourceBergen in a report on Tuesday, February 27th. Two research analysts have rated the stock with a sell rating, six have given a hold rating, eleven have given a buy rating and one has assigned a strong buy rating to the company’s stock. AmerisourceBergen presently has an average rating of “Buy” and a consensus price target of $102.72.

Shares of NYSE:ABC traded up $2.03 on Friday, hitting $90.80. The company’s stock had a trading volume of 992,625 shares, compared to its average volume of 2,006,340. AmerisourceBergen has a 1 year low of $71.90 and a 1 year high of $106.27. The stock has a market cap of $19,071.66, a P/E ratio of 15.42, a PEG ratio of 1.31 and a beta of 1.06. The company has a quick ratio of 0.50, a current ratio of 0.95 and a debt-to-equity ratio of 1.61.

In other news, Chairman Steven H. Collis sold 21,350 shares of AmerisourceBergen stock in a transaction that occurred on Thursday, February 1st. The stock was sold at an average price of $98.58, for a total value of $2,104,683.00. Following the sale, the chairman now directly owns 287,925 shares in the company, valued at approximately $28,383,646.50. The sale was disclosed in a filing with the SEC, which is available through this link. Also, CFO Tim G. Guttman sold 11,600 shares of AmerisourceBergen stock in a transaction that occurred on Thursday, April 5th. The stock was sold at an average price of $85.60, for a total value of $992,960.00. Following the completion of the sale, the chief financial officer now owns 56,472 shares in the company, valued at $4,834,003.20. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 154,809 shares of company stock worth $14,446,032. 27.30% of the stock is owned by corporate insiders.

Several hedge funds have recently modified their holdings of ABC. Hikari Tsushin Inc. purchased a new position in AmerisourceBergen during the fourth quarter valued at $106,000. Delpha Capital Management LLC purchased a new position in AmerisourceBergen during the fourth quarter valued at $137,000. Vantage Investment Advisors LLC purchased a new position in AmerisourceBergen during the fourth quarter valued at $156,000. TRUE Private Wealth Advisors purchased a new position in AmerisourceBergen during the fourth quarter valued at $203,000. Finally, IBM Retirement Fund purchased a new position in AmerisourceBergen during the fourth quarter valued at $216,000. Hedge funds and other institutional investors own 66.88% of the company’s stock.

COPYRIGHT VIOLATION WARNING: This piece was published by Daily Political and is owned by of Daily Political. If you are viewing this piece on another website, it was illegally copied and reposted in violation of United States and international copyright & trademark laws. The original version of this piece can be accessed at https://www.dailypolitical.com/2018/04/17/amerisourcebergen-abc-expected-to-post-quarterly-sales-of-40-49-billion.html.

About AmerisourceBergen

AmerisourceBergen Corporation sources and distributes pharmaceutical products in the United States and internationally. Its Pharmaceutical Distribution segment distributes brand-name and generic pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, outsourced compounded sterile preparations, and related services to various healthcare providers, including acute care hospitals and health systems, independent and chain retail pharmacies, mail order pharmacies, medical clinics, long-term care and other alternate site pharmacies, and other customers.

Get a free copy of the Zacks research report on AmerisourceBergen (ABC)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for AmerisourceBergen (NYSE:ABC)

Receive News & Ratings for AmerisourceBergen Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AmerisourceBergen and related companies with MarketBeat.com's FREE daily email newsletter.